3-month gap between doses improves immune response: AstraZeneca vaccine co-developerThe statement assumes significance given the controversy that erupted over the recent change in the prescribed time interval between two Co...
19 May, 2021, 10.22 AM IST
Does the world need new COVID vaccines? 'Jury is out', says Oxford's Pollard"I think the jury is out on that at the moment, but all developers are preparing new vaccines so if we do need them, we'll have them availa...
09 Feb, 2021, 02.21 PM IST
AstraZeneca: Vaccine may work against UK variantAndrew Pollard of Oxford University, which helped develop the AstraZeneca vaccine, says the shot also appears to reduce the amount of virus...
05 Feb, 2021, 09.51 PM IST
AstraZeneca, Oxford expect 'next generation' COVID-19 vaccine to tackle variants by autumn - executiveAsked when AstraZeneca could produce a next generation vaccine to tackle new variants, AstraZeneca research chief Mene Pangalos said "as ra...
03 Feb, 2021, 05.31 PM IST
AstraZeneca says vaccine 76% effective for 90 days after single doseThe primary analysis of the Phase 3 clinical trials, published as a preprint in The Lancet, also showed that with an inter-dose interval of...
03 Feb, 2021, 05.26 PM IST
'So pleased' - Britain gives first dose of Oxford/AstraZeneca vaccine to dialysis patientPinker, a retired maintenance manager, paid tribute to the scientists who had developed the shot, saying he was looking forward to celebrat...
04 Jan, 2021, 03.26 PM IST
Evidence of coronavirus vaccines working in a 'half-measure' takes experts by surpriseSarah Gilbert, professor at Oxford's Nuffield Department of Medicine, said the better result with a smaller initial dose could be because t...
23 Nov, 2020, 09.05 PM IST
Some signs AstraZeneca vaccine durability could be a year: Chief investigator"We don't know yet if this virus will be mutating away from the immune response," the Oxford vaccine group's director Andrew Pollard told r...
23 Nov, 2020, 04.44 PM IST
Oxford COVID-19 vaccine efficacy would look higher if trial tested for severe virusSpeaking in a briefing, Andrew Pollard, director of the Oxford Vaccine Group, said it is hard to explain the different efficacy rates betwe...
23 Nov, 2020, 03.54 PM IST
Oxford's COVID-19 vaccine trial results 'definitely' before Christmas - investigatorAsked if it was too early to say whether the vaccine, which is licensed to AstraZeneca, stops disease developing, Andrew Pollard, director ...
19 Nov, 2020, 11.39 PM IST
Oxford Covid trial will look at interim Phase III data after 53 infections: InvestigatorThe Oxford Vaccine Group's director, Andrew Pollard, said in a media briefing there were "lots of cases" of infections in its Phase III tri...
19 Nov, 2020, 05.16 PM IST
Different regulatory timelines for COVID vaccine no issue, Oxford trial chief says"I would not imagine that either developers can submit for approval in all regulatory authorities at the same time, or that all regulatory ...
04 Nov, 2020, 05.13 PM IST
Oxford COVID-19 vaccine trial results due this year, trial chief says"I'm optimistic that we could reach that point before the end of this year," chief trial investigator for the vaccine, Andrew Pollard said ...
04 Nov, 2020, 05.08 PM IST
Oxford expands vaccine trial to older adults, kidsOxford’s effort involves its multidisciplinary Vaccine Group, set up in 1994 to study new and improved inoculations, and the Jenner Institu...
22 May, 2020, 11.09 PM IST
Cricket and more: Kohli vs Rabada, and other interesting duels to look forward toSome interesting duos cricket fans would love to see.
06 Apr, 2018, 12.39 PM IST
IPL 2017: Mumbai Indians beat Gujarat Lions in a thrillerMumbai Indians today had a comfortable win against Gujarat Lions.
16 Apr, 2017, 07.47 PM IST
- New meningitis vaccine for infants shows promise
A new vaccine, Menveo, has shown promise in clinical trials, which might help protect infants against four types of meningitis.
17 Nov, 2007, 05.30 PM IST